Document is current

Any future updates will be listed below

Long-Term Treatment with Eldecalcitol (1α, 25-Dihydroxy-2β- (3-hydroxypropyloxy) Vitamin D3) Suppresses Bone Turnover and Leads to Prevention of Bone Loss and Bone Fragility in Ovariectomized Rats

Crossref DOI link: https://doi.org/10.1007/s00223-014-9937-5

Published Online: 2014-12-04

Published Print: 2015-01

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark